Quantum Biopharma Files October 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Oct 2, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, company-update
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its monthly 6-K report on Oct 2, 2025.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 2, 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, is in the pharmaceutical preparations industry. This filing is a report of a foreign private issuer for the month of October 2025.
Why It Matters
This filing provides routine updates for Quantum Biopharma Ltd. as a foreign private issuer, informing investors about its ongoing reporting status.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational disclosures that would indicate immediate risk.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the report
- FSD Pharma Inc. (company) — Former name of Quantum Biopharma Ltd.
- October 2, 2025 (date) — Filing date and reporting period
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
When was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd. is headquartered at 1 Adelaide Street East, Suite 801, Toronto, Ontario, M5C 2V9.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Does Quantum Biopharma Ltd. file under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-10-02 07:57:03
Filing Documents
- f6k_100225.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 8KB
- 0001171843-25-006238.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 2, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 2, 2025